Article
Activation of ERK1/2 occurs independently of KRAS or BRAF status in endometrial cancer and is associated with favorable prognosis.
Cancer science - 1 May 2007
Mizumoto Yasunari, Kyo Satoru, Mori Noriko, Sakaguchi Junko, Ohno Satoshi, Maida Yoshiko, Hashimoto Manabu, Takakura Masahiro, Inoue Masaki
Abstract excerpt
The extracellular-regulated kinase (ERK) signaling pathway plays important roles in regulating the malignant potential of cancer cells in vitro. However, the effect of ERK signaling on the prognosis of human tumors is not clearly understood. The present study examined the expression of phosphorylated ERK1/2 (p-ERK1/2) as a hallmark of ERK activation, in relation to KRAS and BRAF mutations, in 63 endometrial...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
